A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation

Clinical trial NCT06946927 · RECRUITING

Trial details

NCT number: NCT06946927
Sponsor: Jemincare
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2025-06-06
Primary completion: 2026-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.